During the past decade, Ospedale di Sondrio conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale di Sondrio" #1 sponsor was "National Cancer Institute, Naples" with 3 trials, followed by "Regione Lombardia" with 2 trials sponsored, "Associazione Volontari Pazienti Oncologici" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale di Sondrio" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 4 trials as a collaborator, "Istituto Clinico Humanitas" with 2 trials as a collaborator, "A.O. Ospedale Papa Giovanni XXIII" with 1 trials as a collaborator, "Everest Medicines" with 1 trials as a collaborator and "Istituto Nazionale Tumori di Napoli" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale di Sondrio" are "Colorectal Cancer" (2 trials), "Head and Neck Squamous Cell Carcinoma" (1 trials), "Locally Advanced or Metastatic Unresectable Urothelial Cancer" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Metastatic or Locally Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Ospedale di Sondrio" in a lesser frequency.

Most popular intervention types in "Ospedale di Sondrio" are "Drug" (9 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (3 trials), "Bevacizumab" (2 trials), "Paclitaxel" (2 trials), "Carboplatin" (1 trials) and "Cetuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale di Sondrio" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale di Sondrio". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Ospedale di Sondrio, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale di Sondrio, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".